IPP Bureau
Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
By IPP Bureau - July 28, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Dr. Lal Path Labs Q1FY24 consolidated PAT up at Rs. 82.6 Cr
By IPP Bureau - July 28, 2023
Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023
Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr
By IPP Bureau - July 28, 2023
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer
By IPP Bureau - July 28, 2023
Marks the World Head & Neck Cancer Day at the OCTF Conference
GenWorks introduces mechanical hysteroscopic tissue removal system
By IPP Bureau - July 28, 2023
Uses a simple mechanical approach for removing intrauterine tissues
Cipla reports jump in Q1FY24 consolidated PAT to Rs. 995.70 Cr
By IPP Bureau - July 27, 2023
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Eugia Pharma receives USFDA approval for Plerixafor Injection
By IPP Bureau - July 26, 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
TransCure bioServices partners with Preclina to expands reach into APAC
By IPP Bureau - July 26, 2023
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Teva Pharmaceuticals engages Honeywell to help reduce carbon impact
By IPP Bureau - July 26, 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
InnoCare gets approval of clinical trial of Zurletrectinib for the treatment of pediatric patients in China
By IPP Bureau - July 26, 2023
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Robotic surgery enhances success rate in knee replacements
By IPP Bureau - July 26, 2023
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Akums gets approval for triple combination diabetes treatment
By IPP Bureau - July 26, 2023
Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr
By IPP Bureau - July 26, 2023
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Adlib and Generis launch software connector to increases automation and compliant management of document repositories
By IPP Bureau - July 26, 2023
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
